Intermountain Cottonwood Dayspring Add Treatment Services is an addiction and mental health treatment facility located at 5770 South 250 East, Suite 300 in the 84107 zip code in Salt Lake City, UT.
It is operated by a private non-profit organization. Intermountain Cottonwood Dayspring Add Treatment Services provides buprenorphine for pain management, suboxone prescription and buprenorphine detox. Some of the treatment approaches used by Intermountain Cottonwood Dayspring Add Treatment Services include CBT, anger management and substance use counseling approach. Intermountain Cottonwood Dayspring Add Treatment Services also specializes in detox services and offers inpatient opioid detoxification. Intermountain Cottonwood Dayspring Add Treatment Services provides outpatient detoxification, outpatient day treatment and outpatient methadone/buprenorphine or naltrexone treatment. It also provides inpatient treatment for co-occurring mental health and substance use disorders, residential treatment for substance use and inpatient detoxification. Other addiction treatment offered includes general addiction disorder treatment and gambling disorder treatment.
Here are the full facility listing details on Intermountain Cottonwood Dayspring Add Treatment Services in Salt Lake City, UT:
Types of Care:
- inpatient detox
- residential substance abuse treatment
- inpatient treatment for dual diagnosis
Service Settings:
- outpatient rehabilitation
- outpatient detox services
- outpatient day treatment
- intensive outpatient treatment
- outpatient methadone/buprenorphine or naltrexone treatment
- regular outpatient treatment
Opioid Medications used in Treatment:
- Buprenorphine clinical treatment
- Naltrexone treatment
Type of Alcohol Use Disorder Treatment:
- Administers medication for alcohol use disorder
Type Of Treatment:
- buprenorphine detoxification
- buprenorphine maintenance
- suboxone prescription
- administers naltrexone
- relapse prevention from naltrexone
- methadone for pain management
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine sub-dermal implant (Probuphine)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable, for example, Sublocade)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
Treatment Approaches:
- anger management
- brief intervention services
- CBT
- motivational interviewing
- relapse prevention treatment
- substance use counseling approach
- counseling for trauma victims
- 12-step rehab
Facility Ownership:
- a private non-profit organization
License/Certification/Accreditation:
- State department of health
- Certified by The Joint Commission
Payment/Insurance/Funding Accepted:
- Accepts private health insurance
- Accepts cash
Special Programs/ Population Groups Supported:
- rehab for adult women
- rehab for adult men
- people with trauma
Assessment/Pre-treatment:
- Comprehensive substance use assessment
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Ancillary Services:
- mental health services
- self help meetings
- drug addiction intervention
- group meetings
Other Addictions Treatment:
- treatment for non-substance use addiction disorder
- treatment for gambling disorder
Detoxification:
Counseling Services and Education:
- counseling for individuals
- group counseling
- counseling for families
- marital/couples counseling
- substance use education
- health education services
Tobacco/Screening Services:
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
Age Groups Accepted:
- accepts adults
- accepts young adults
Gender Accepted:
Call (888) 303-2026 to get 24/7 help with treatment.
SPONSORED AD
